David Portnoy, Chairman and Co-CEO of Cryo-Cell International (CCEL), has been a consistent accumulator of the company's stock, with SEC Form 4 filings revealing a pronounced buy-side bias. Across 40 reported transactions in the past year, Portnoy has not recorded a single open-market sale, instead deploying roughly $531,000 in open-market purchases (code "P") while also receiving approximately $1.27 million in stock awards (code "A"). The most recent activity, however, skews heavily toward compensation: all ten of his latest filings, dated between November 2025 and January 2026, are grants or awards rather than discretionary purchases, including two large awards on January 7, 2026, valued at $583,500 and $194,500.
The pattern shifts when looking at the prior quarter. Between September 9 and September 18, 2025, Portnoy executed ten open-market purchases of CCEL totaling roughly $220,000, with individual transactions ranging from $699 to $48,554. These clustered buys—several occurring on the same day, such as five separate purchases on September 10—suggest a deliberate accumulation phase rather than sporadic buying. The absence of any "S" (sale) or "D" (disposition) codes throughout the entire filing history reinforces a directional stance: Portnoy has only added to his position, never reduced it, during the covered period.
The recent shift from active buying to passive awards is notable. While the September purchases demonstrate conviction, the November-through-January filings consist entirely of compensation-related grants, including small monthly awards (e.g., $1,119 to $10,218 in late November) and the two large January grants. This transition does not indicate selling pressure—there are zero sales on record—but it does mean Portnoy's most recent insider activity reflects corporate compensation mechanics rather than fresh capital commitment. The overall trajectory remains one of accumulation, with the buy-side total dwarfing any potential dilution from the automatic tax-withholding code ("F") that typically accompanies such grants.
AI-assisted summary